INTERPLAY BETWEEN RENAL FUNCTION AND ENDOCRINE REGULATION IN METABOLIC SYNDROME

Abstract

This paper reviewed the multi-factorial interplay between renal function and endocrine regulation in patients with metabolic syndrome consisting of the inter-relations of quantitative bio-chemical profile and qualitative clinical analysis.  The result showed a statistically significant and robust relationship between the decline in renal filtration capacity and the disproportion of the most critical endocrine markers, including increased insulin resistance, altered adipokine ratios, and amplified cortisol synthesis. eGFR was always negatively correlated with HOMA-IR outcomes, indicating that the decline of insulin resistance is the precursor of early renal dysfunction even before a patient develops chronic kidney disease.  Similarly leptin serum levels were significantly higher in individuals with reduced renal clearance. This is in keeping with the notion that those issues pertaining to adipokine metabolism contribute to the metabolic-renal burden.  The effects of thyroid hormones proved to be measurable because low levels of free T3 were found to be linked to a decrease in eGFR and an increase in creatinine levels.  These results were supported by qualitative clinical interviews, which highlighted lifestyle patterns such as low quality of sleep, high levels of felt stress, and unreliable eating habits that were strongly linked with changes in hormones and kidney stress.  Direct and indirect pathways were supported in structural equation modeling, which demonstrated that endocrine instability contributes to renal damage through metabolic stresses that act in a synergistic way.  Overall, the findings indicate that the renal and endocrine systems cooperate in both directions and the issues in one system cause the issues in the other system to occur increasingly quickly by intermediated by metabolic routes that are related.  These findings demonstrate the importance of screening hormones in people with metabolic syndrome at an early stage and provide considerable support to the integrated diagnostic models that can identify renal-endocrine co-regulation rather than considering these systems separately.